These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 9652847

  • 1. Effect of filgrastim (G-CSF) during chemotherapy and abdomino-pelvic radiation therapy in patients with ovarian carcinoma.
    Fyles AW, Manchul L, Levin W, Robertson JM, Sturgeon J, Tsuji D.
    Int J Radiat Oncol Biol Phys; 1998 Jul 01; 41(4):843-7. PubMed ID: 9652847
    [Abstract] [Full Text] [Related]

  • 2. Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study.
    Glisson B, Komaki R, Lee JS, Shin DM, Fossella F, Murphy WK, Kurie J, Perez-Soler R, Schea R, Vadhan-Raj S.
    Int J Radiat Oncol Biol Phys; 1998 Jan 15; 40(2):331-6. PubMed ID: 9457817
    [Abstract] [Full Text] [Related]

  • 3. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
    Vokes EE, Haraf DJ, Drinkard LC, Hoffman PC, Ferguson MK, Vogelzang NJ, Watson S, Lane NJ, Golomb HM.
    Cancer Chemother Pharmacol; 1995 Jan 15; 35(4):304-12. PubMed ID: 7530173
    [Abstract] [Full Text] [Related]

  • 4. Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies.
    Stahel RA, Jost LM, Cerny T, Pichert G, Honegger H, Tobler A, Jacky E, Fey M, Platzer E.
    J Clin Oncol; 1994 Sep 15; 12(9):1931-8. PubMed ID: 7521907
    [Abstract] [Full Text] [Related]

  • 5. A study of ovarian cancer patients treated with dose-intensive chemotherapy supported with peripheral blood progenitor cells mobilised by filgrastim and cyclophosphamide.
    Weaver A, Wrigley E, Watson A, Chang J, Collins CD, Jenkins B, Gill C, Pettengell R, Dexter TM, Testa NG, Crowther D.
    Br J Cancer; 1996 Dec 15; 74(11):1821-7. PubMed ID: 8956800
    [Abstract] [Full Text] [Related]

  • 6. A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor (R-MeTHuG-CSF, filgrastim) in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma (NHL). The Central Lymphoma Group.
    Smith GM, Child JA, Cullen MH, Bailey NP, Woodruffe CM, Fletcher J, Earl H, Barnard D.
    Hematol Oncol; 1996 Dec 15; 14(4):193-201. PubMed ID: 9267465
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor.
    MacVittie TJ, Farese AM, Herodin F, Grab LB, Baum CM, McKearn JP.
    Blood; 1996 May 15; 87(10):4129-35. PubMed ID: 8639770
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phase I dose escalation of paclitaxel in patients with advanced ovarian cancer receiving cisplatin: rapid development of neurotoxicity is dose-limiting.
    Gordon AN, Stringer CA, Matthews CM, Willis DL, Nemunaitis J.
    J Clin Oncol; 1997 May 15; 15(5):1965-73. PubMed ID: 9164208
    [Abstract] [Full Text] [Related]

  • 12. Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study.
    Veldhuis GJ, Willemse PH, Beijnen JH, Boonstra H, Piersma H, van der Graaf WT, de Vries EG.
    Br J Cancer; 1997 May 15; 75(5):703-9. PubMed ID: 9043028
    [Abstract] [Full Text] [Related]

  • 13. Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial.
    Ottmann OG, Hoelzer D, Gracien E, Ganser A, Kelly K, Reutzel R, Lipp T, Busch FW, Schwonzen M, Heil G.
    Blood; 1995 Jul 15; 86(2):444-50. PubMed ID: 7541660
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients.
    Shapiro CL, Ayash L, Webb IJ, Gelman R, Keating J, Williams L, Demetri G, Clark P, Elias A, Duggan D, Hayes D, Hurd D, Henderson IC.
    J Clin Oncol; 1997 Feb 15; 15(2):674-83. PubMed ID: 9053493
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.